Xvivo Perfusion AB (publ) Profit Margin

Xvivo Perfusion AB (publ) (XVIPF) currently reports a profit margin of 13.44% as of September 2026. That compares with 3.68% in the prior-year period — up 265.7% year over year. That is above the sector sector average of 13.23%. Use the charts on this page to explore Xvivo Perfusion AB (publ)'s profit margin history and peer comparisons.

Xvivo Perfusion AB (publ)'s profit margin increased from 3.68% to 13.44% — a 265.7% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Xvivo Perfusion AB (publ)'s profit margin of 13.44% is higher than the its sector sector average of 13.23%. That is roughly 1.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Xvivo Perfusion AB (publ)'s current 13.44% should be judged against industry norms (sector average: 13.23%) and against XVIPF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 13.44%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Xvivo Perfusion AB (publ), and consider following XVIPF for alerts when major investors trade the stock.